<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T01:28:00Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:11351/7388" metadataPrefix="mets">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:11351/7388</identifier><datestamp>2025-10-24T10:24:22Z</datestamp><setSpec>com_2072_378070</setSpec><setSpec>com_2072_378040</setSpec><setSpec>col_2072_378092</setSpec></header><metadata><mets xmlns="http://www.loc.gov/METS/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" ID="&#xa;&#x9;&#x9;&#x9;&#x9;DSpace_ITEM_11351-7388" TYPE="DSpace ITEM" PROFILE="DSpace METS SIP Profile 1.0" xsi:schemaLocation="http://www.loc.gov/METS/ http://www.loc.gov/standards/mets/mets.xsd" OBJID="&#xa;&#x9;&#x9;&#x9;&#x9;hdl:11351/7388">
   <metsHdr CREATEDATE="2026-04-17T03:28:00Z">
      <agent ROLE="CUSTODIAN" TYPE="ORGANIZATION">
         <name>RECERCAT</name>
      </agent>
   </metsHdr>
   <dmdSec ID="DMD_11351_7388">
      <mdWrap MDTYPE="MODS">
         <xmlData xmlns:mods="http://www.loc.gov/mods/v3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
            <mods:mods xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Rosales, Alejandra</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Madrid Aris, Alvaro Domingo</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Muñoz López, Marina</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Dapena Diaz, Jose Luis</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Ariceta Iraola, Gema</mods:namePart>
               </mods:name>
               <mods:extension>
                  <mods:dateAccessioned encoding="iso8601">2025-10-24T10:24:22Z</mods:dateAccessioned>
               </mods:extension>
               <mods:extension>
                  <mods:dateAvailable encoding="iso8601">2025-10-24T10:24:22Z</mods:dateAvailable>
               </mods:extension>
               <mods:originInfo>
                  <mods:dateIssued encoding="iso8601">2022-04-22T15:42:21Z2022-04-22T15:42:21Z2021-08</mods:dateIssued>
               </mods:originInfo>
               <mods:identifier type="none"/>
               <mods:identifier type="uri">http://hdl.handle.net/11351/7388</mods:identifier>
               <mods:abstract>Carbó vegetal; Glucarpidasa; Toxicitat del metotrexatCarbón vegetal; Glucarpidasa; Toxicidad del metotrexatoCharcoal; Glucarpidase; Methotrexate toxicityBackground: High dose methotrexate (HDMTX) is used for the treatment of pediatric hemato-oncological diseases. HDMTX can induce acute kidney injury in cases of delayed elimination. The use of leucovorin remains the most effective rescue action. Further treatment options are of difficult access in the rare cases where leucovorin fails to prevent renal failure from occurring. Glucarpidase is an effective treatment in cases of methotrexate (MTX) delayed elimination, but cost is high and availability is limited. Charcoal hemoperfusion (CHP) is a very efficient procedure to remove protein-bound drugs, promoting fast MTX elimination, but is rarely considered as a treatment option.&#xd;
Methods: We present three pediatric cases with prolonged exposure to MTX after HDMTX and delayed elimination in which hemoperfusion was performed as rescue treatment for methotrexate intoxication.&#xd;
&#xd;
Results: Charcoal hemoperfusion was performed with positive results and no complications as bridging until glucarpidase was available in two cases and in one case where two doses of glucarpidase led to insufficient reduction of MTX levels.&#xd;
Conclusions: CHP can be considered as a rescue treatment option in MTX intoxication, since it is an effective and safe extracorporeal method for removing MTX, in cases where rescue with leucovorin is insufficient and glucarpidase is not available or while waiting for delivery.</mods:abstract>
               <mods:language>
                  <mods:languageTerm authority="rfc3066"/>
               </mods:language>
               <mods:accessCondition type="useAndReproduction">Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess</mods:accessCondition>
               <mods:subject>
                  <mods:topic>Infants - Malalties - Tractament</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Hematologia oncològica</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Metotrexat - Depuració</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>DISEASES::Neoplasms::Neoplasms by Site::Hematologic Neoplasms</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Other subheadings::Other subheadings::Other subheadings::/drug therapy</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>DISCIPLINES AND OCCUPATIONS::Health Occupations::Medicine::Pediatrics</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Sorption Detoxification::Hemoperfusion</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>DISCIPLINAS Y OCUPACIONES::profesiones sanitarias::medicina::pediatría</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias hematológicas</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::desintoxicación por adsorción::hemoperfusión</mods:topic>
               </mods:subject>
               <mods:titleInfo>
                  <mods:title>Charcoal Hemoperfusion for Methotrexate Toxicity: A Safe and Effective Life-Rescue Alternative When Glucarpidase Is Not Available</mods:title>
               </mods:titleInfo>
               <mods:genre>info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion</mods:genre>
            </mods:mods>
         </xmlData>
      </mdWrap>
   </dmdSec>
   <structMap LABEL="DSpace Object" TYPE="LOGICAL">
      <div TYPE="DSpace Object Contents" ADMID="DMD_11351_7388"/>
   </structMap>
</mets></metadata></record></GetRecord></OAI-PMH>